209 related articles for article (PubMed ID: 33109600)
1.
Christensen EM; Bogner AN; Vandekeere A; Tam GS; Patel SM; Becker DF; Fendt SM; Tanner JJ
J Biol Chem; 2020 Dec; 295(52):18316-18327. PubMed ID: 33109600
[TBL] [Abstract][Full Text] [Related]
2. Novel Fragment Inhibitors of PYCR1 from Docking-Guided X-ray Crystallography.
Meeks KR; Ji J; Protopopov MV; Tarkhanova OO; Moroz YS; Tanner JJ
J Chem Inf Model; 2024 Mar; 64(5):1704-1718. PubMed ID: 38411104
[TBL] [Abstract][Full Text] [Related]
3. Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1.
Christensen EM; Patel SM; Korasick DA; Campbell AC; Krause KL; Becker DF; Tanner JJ
J Biol Chem; 2017 Apr; 292(17):7233-7243. PubMed ID: 28258219
[TBL] [Abstract][Full Text] [Related]
4. Expression and kinetic characterization of PYCR3.
Meeks KR; Tanner JJ
Arch Biochem Biophys; 2023 Jan; 733():109468. PubMed ID: 36414121
[TBL] [Abstract][Full Text] [Related]
5. A fragment-like approach to PYCR1 inhibition.
Milne K; Sun J; Zaal EA; Mowat J; Celie PHN; Fish A; Berkers CR; Forlani G; Loayza-Puch F; Jamieson C; Agami R
Bioorg Med Chem Lett; 2019 Sep; 29(18):2626-2631. PubMed ID: 31362921
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of human pyrroline-5-carboxylate reductase in L-thioproline metabolism.
Patel SM; Seravalli J; Stiers KM; Tanner JJ; Becker DF
Amino Acids; 2021 Dec; 53(12):1863-1874. PubMed ID: 34792644
[TBL] [Abstract][Full Text] [Related]
7. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix.
Kay EJ; Paterson K; Riera-Domingo C; Sumpton D; Däbritz JHM; Tardito S; Boldrini C; Hernandez-Fernaud JR; Athineos D; Dhayade S; Stepanova E; Gjerga E; Neilson LJ; Lilla S; Hedley A; Koulouras G; McGregor G; Jamieson C; Johnson RM; Park M; Kirschner K; Miller C; Kamphorst JJ; Loayza-Puch F; Saez-Rodriguez J; Mazzone M; Blyth K; Zagnoni M; Zanivan S
Nat Metab; 2022 Jun; 4(6):693-710. PubMed ID: 35760868
[TBL] [Abstract][Full Text] [Related]
9. Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target.
Bogner AN; Stiers KM; Tanner JJ
Amino Acids; 2021 Dec; 53(12):1817-1834. PubMed ID: 34003320
[TBL] [Abstract][Full Text] [Related]
10. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of Pycr1 and Pycr2 in mice.
Stum MG; Tadenev ALD; Seburn KL; Miers KE; Poon PP; McMaster CR; Robinson C; Kane C; Silva KA; Cliften PF; Sundberg JP; Reinholdt LG; John SWM; Burgess RW
Genetics; 2021 May; 218(1):. PubMed ID: 33734376
[TBL] [Abstract][Full Text] [Related]
12. Functional Impact of a Cancer-Related Variant in Human Δ
Daudu OI; Meeks KR; Zhang L; Seravalli J; Tanner JJ; Becker DF
ACS Omega; 2023 Jan; 8(3):3509-3519. PubMed ID: 36713721
[TBL] [Abstract][Full Text] [Related]
13. Phenyl-substituted aminomethylene-bisphosphonates inhibit human P5C reductase and show antiproliferative activity against proline-hyperproducing tumour cells.
Forlani G; Sabbioni G; Ragno D; Petrollino D; Borgatti M
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1248-1257. PubMed ID: 34107832
[TBL] [Abstract][Full Text] [Related]
14. Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions.
Westbrook RL; Bridges E; Roberts J; Escribano-Gonzalez C; Eales KL; Vettore LA; Walker PD; Vera-Siguenza E; Rana H; Cuozzo F; Eskla KL; Vellama H; Shaaban A; Nixon C; Luuk H; Lavery GG; Hodson DJ; Harris AL; Tennant DA
Cell Rep; 2022 Feb; 38(5):110320. PubMed ID: 35108535
[TBL] [Abstract][Full Text] [Related]
15. Human pyrroline-5-carboxylate reductase (PYCR1) acts on Δ(1)-piperideine-6-carboxylate generating L-pipecolic acid.
Struys EA; Jansen EE; Salomons GS
J Inherit Metab Dis; 2014 May; 37(3):327-32. PubMed ID: 24431009
[TBL] [Abstract][Full Text] [Related]
16. SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism.
Chen S; Yang X; Yu M; Wang Z; Liu B; Liu M; Liu L; Ren M; Qi H; Zou J; Vucenik I; Zhu WG; Luo J
Neoplasia; 2019 Jul; 21(7):665-675. PubMed ID: 31108370
[TBL] [Abstract][Full Text] [Related]
17. The Proline Cycle As a Potential Cancer Therapy Target.
Tanner JJ; Fendt SM; Becker DF
Biochemistry; 2018 Jun; 57(25):3433-3444. PubMed ID: 29648801
[TBL] [Abstract][Full Text] [Related]
18. Purification, characterization, and crystallization of human pyrroline-5-carboxylate reductase.
Meng Z; Lou Z; Liu Z; Hui D; Bartlam M; Rao Z
Protein Expr Purif; 2006 Sep; 49(1):83-7. PubMed ID: 16600630
[TBL] [Abstract][Full Text] [Related]
19. Disease variants of human Δ
Patel SM; Seravalli J; Liang X; Tanner JJ; Becker DF
Arch Biochem Biophys; 2021 May; 703():108852. PubMed ID: 33771508
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of proline in Pseudomonas aeruginosa. Properties of gamma-glutamyl phosphate reductase and 1-pyrroline-5-carboxylate reductase.
Krishna RV; Beilstein P; Leisinger T
Biochem J; 1979 Jul; 181(1):223-30. PubMed ID: 114173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
